Renal cell carcinoma and Renal function test abnormal

Summary:

Renal function test abnormal is found among people with Renal cell carcinoma, especially for people who are male, 60+ old.

The study analyzes which people have Renal function test abnormal with Renal cell carcinoma. It is created by eHealthMe based on reports of 89 people who have Renal cell carcinoma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Renal cell carcinoma?

Renal cell carcinoma (a kidney cancer) is found to be associated with 787 drugs and 1,339 conditions by eHealthMe. Check the latest studies of Renal cell carcinoma.

What is Renal function test abnormal?

Renal function test abnormal is found to be associated with 499 drugs and 566 conditions by eHealthMe. Check the latest studies of Renal function test abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

89 people who have Renal Cell Carcinoma and Renal Function Test Abnormal are studied.

Would you have Renal function test abnormal when you have Renal cell carcinoma?

Gender of people who have Renal Cell Carcinoma and experienced Renal Function Test Abnormal *:

female: 31.65 %
male: 68.35 %

Age of people who have Renal Cell Carcinoma and experienced Renal Function Test Abnormal *:

Common co-existing conditions for these people *:

Metastases To Bone (cancer spreads to bone): 11 people, 12.36%
Diabetes: 8 people, 8.99%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 2.25%
Breast Cancer: 2 people, 2.25%
Gastrointestinal Carcinoma (cancer of stomach or intestine): 2 people, 2.25%
High Blood Pressure: 2 people, 2.25%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 2.25%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 2.25%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 2.25%
Prostate Cancer: 2 people, 2.25%

Common drugs taken by these people *:

Common symptoms for these people *:

Fatigue (feeling of tiredness): 31 people, 34.83%
Diarrhea: 25 people, 28.09%
High Blood Pressure: 23 people, 25.84%
Nausea (feeling of having an urge to vomit): 20 people, 22.47%
Liver Function Test Abnormal: 18 people, 20.22%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 15 people, 16.85%
Stomatitis (inflammation of mucous membrane of mouth): 12 people, 13.48%
Constipation: 10 people, 11.24%
Nausea And Vomiting: 10 people, 11.24%
Hepatic Enzyme Increased: 9 people, 10.11%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Renal function test abnormal?

- Check whether Renal function test abnormal is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Renal function test abnormal and Renal cell carcinoma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.